Yang, Yi-Ching

Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial

Aronne, L. J., Sattar, N., Horn, D. B., Bays, H. E., Wharton, S., Lin, W.-Y., Ahmad, N. N., Zhang, S., Liao, R., Bunck, M. C., et al. (2024) · JAMA

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 860

The risk factors of Internet addiction—A survey of university freshmen

Tsai, H. F., Cheng, S. H., Yeh, T. L., Shih, C.-C., Chen, K. C., Yang, Y. C., & Yang, Y. K. (2009) · Psychiatry Research

Impact of Technology on AdolescentsSexuality, Behavior, and Technology

Cited by 368

Sleep duration is a potential risk factor for newly diagnosed type 2 diabetes mellitus

Chao, C.-Y., Wu, J.-S., Yang, Y.-C., Shih, C.-C., Wang, R.-H., Lu, F.-H., & Chang, C.-J. (2011) · Metabolism

Sleep and related disordersCircadian rhythm and melatonin

Cited by 110

Epidemiological evidence of altered cardiac autonomic function in subjects with impaired glucose tolerance but not isolated impaired fasting glucose

Wu, J.-S., Yang, Y.-C., Lin, T.-S., Huang, Y.-H., Chen, J.-J., Lu, F.-H., Wu, C.-H., & Chang, C.-J. (2007) · The Journal of Clinical Endocrinology & Metabolism

Heart Rate Variability and Autonomic ControlDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 98

A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes

Wu, H.-T., Ou, H.-Y., Hung, H.-C., Su, Y.-C., Lu, F.-H., Wu, J.-S., Yang, Y.-C., Wu, C.-L., & Chang, C.-J. (2016) · Diabetologia

Adipokines, Inflammation, and Metabolic DiseasesLiver Disease Diagnosis and Treatment

Cited by 96

The role of hepassocin in the development of non-alcoholic fatty liver disease

Wu, H.-T., Lu, F.-H., Ou, H.-Y., Su, Y.-C., Hung, H.-C., Wu, J.-S., Yang, Y.-C., Wu, C.-L., & Chang, C.-J. (2013) · Journal of Hepatology

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 92